Ticker Details
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
IPO Date:	May 11, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.41B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.16 | 2.69%
Avg Daily Range (30 D):	$0.33 | 3.33%
Avg Daily Range (90 D):	$0.42 | 3.88%

Institutional Daily Volume
Avg Daily Volume:	.89M
Avg Daily Volume (30 D):	1.93M
Avg Daily Volume (90 D):	2.28M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	82
Avg Trade Size (Sh.) (90 D):	90

Institutional Trades
Total Institutional Trades:	5,627
Avg Institutional Trade:	$3.06M
Avg Institutional Trade (30 D):	$2.41M
Avg Institutional Trade (90 D):	$2.39M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.88M
Avg Closing Trade (30 D):	$3.5M
Avg Closing Trade (90 D):	$3.64M
Avg Closing Volume:	126.84K

News

Mar 23, 2026 @ 5:17 PM Biohaven Stock Down 70% but One Fund's New $6 Mill... Source: Jonathan Ponciano

Jan 15, 2026 @ 2:48 AM Biohaven (BHVN) Stock Is Trending Overnight â€â... Source: Mohd Haider

Dec 26, 2025 @ 2:26 PM Stock Market Today: Dow Jones, S&P 500, Nasdaq Fut... Source: Rishabh Mishra

Dec 2, 2025 @ 6:00 PM Migraine Clinical Trial Pipeline Expands as 30+ Co... Source: Delveinsight

Nov 19, 2025 @ 10:15 PM Biohaven's Chief Accounting Officer Scooped Up 17,... Source: Robert Izquierdo

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-6.86	$-1.12	$-6.86
Diluted EPS	$-6.86	$-1.12	$-6.86
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-738.82M	$-145.56M	$-738.82M
Operating Income / Loss	$-745.38M	$-142.73M	$-745.38M
Cost of Revenue
Net Cash Flow	$130.24M	$44.4M	$130.24M
PE Ratio